ALLMedicine™ HIV in Pregnancy Center
Research & Reviews 111 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659513
European Journal of Obstetrics, Gynecology, and Reproduct... Chilaka VN, Konje JC
Nov 28th, 2020 - Human immunodeficiency virus (HIV) is an infection with a global prevalence and currently no cure or vaccine. Women living with HIV who become pregnant or who acquire the virus during pregnancy are at risk of both maternal and perinatal morbidity ...
https://emedicine.medscape.com/article/1385488-overview
Apr 1st, 2019 - Overview The reduction in mother-to-child transmission of human immunodeficiency virus (HIV) is regarded as one of the most effective public health initiatives in the United States. In the absence of treatment, the risk of vertical transmission of...
https://doi.org/10.1111/hiv.12720
HIV Medicine; Gilleece DY, Tariq DS et. al.
Mar 14th, 2019 - British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018.|2019|Gilleece DY,Tariq DS,Bamford DA,Bhagani DS,Byrne DL,|diagnosis,drug therapy,diagnosis,drug therapy,
https://doi.org/10.2217/pgs-2018-0111
Pharmacogenomics Gini J, Olagunju A et. al.
Feb 15th, 2019 - Treatment and prevention of mother-to-child transmission of HIV in pregnancy utilizes tenofovir (TFV) and emtricitabine (FTC) as NRTI backbone in combination with a third agent from a different class. We hypothesized that combined effect of pregna...
https://doi.org/10.1080/15321819.2018.1494607
Journal of Immunoassay & Immunochemistry; Afolabi AY, Bakarey AS et. al.
Jul 12th, 2018 - Over 90% of infant acquired immunodeficiency syndrome (AIDS) cases have been through mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV). Consequent to this, prevention of mother-to-child transmission (PMTCT) programs have in...
Guidelines 11 results
https://doi.org/10.1111/hiv.12720
HIV Medicine; Gilleece DY, Tariq DS et. al.
Mar 14th, 2019 - British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018.|2019|Gilleece DY,Tariq DS,Bamford DA,Bhagani DS,Byrne DL,|diagnosis,drug therapy,diagnosis,drug therapy,
https://aidsinfo.nih.gov/guidelines/html/3/perinatal/0
Office of AIDS Research Advisory Council
Dec 6th, 2018 - Recommendations regarding HIV screening in pregnancy, treatment of pregnant women who are living with HIV, and the use of antiretroviral (ARV) drugs for prevention of perinatal transmission of HIV have evolved considerably in the United States sin.
https://aidsinfo.nih.gov/guidelines/html/6/caring-for-persons-with-hiv-in-disaster-areas/0
Office of AIDS Research Advisory Council
Sep 13th, 2018 - The following information provides guidance to health care providers attending to the medical needs of adults and children with HIV who have been displaced from disaster areas and who have not yet secured HIV care in the areas where they have relo.
https://doi.org/10.1016/j.jogc.2017.04.009
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Keenan-Lindsay L, Yudin MH
Jun 19th, 2017 - The purpose of this guideline is to provide recommendations to obstetric health care providers and to minimize practice variations for HIV screening, while taking provincial and territorial recommendations into account. The risk of transmission of...
https://www.ncbi.nlm.nih.gov/books/NBK379872/pdf/Bookshelf_NBK379872.pdf
WHO
Jul 27th, 2016 - WHO guidelines on HIV and Infant Feeding in 2010 for the first time recommended the use of antiretroviral drugs to prevent postnatal transmission of HIV through breastfeeding. This resulted in a major change from an individualised counselling appr.
Clinicaltrials.gov 131 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659513
European Journal of Obstetrics, Gynecology, and Reproduct... Chilaka VN, Konje JC
Nov 28th, 2020 - Human immunodeficiency virus (HIV) is an infection with a global prevalence and currently no cure or vaccine. Women living with HIV who become pregnant or who acquire the virus during pregnancy are at risk of both maternal and perinatal morbidity ...
https://reference.medscape.com/viewarticle/911214_3
Apr 2nd, 2019 - Neonatal Management Two weeks of zidovudine monotherapy should be used if the mother has been on cART for more than 10 weeks, has two recorded maternal HIV viral loads during pregnancy <50 HIV RNA copies/mL at least 4 weeks apart, and a maternal H...
https://reference.medscape.com/viewarticle/911214
Apr 2nd, 2019 - The guidelines on management of HIV in pregnancy and postpartum were released on March 14, 2019, by the British HIV Association (BHIVA).[1] Screening Pregnant women living with HIV should be offered peer support if it is available. Evaluation of a...
https://emedicine.medscape.com/article/1385488-overview
Apr 1st, 2019 - Overview The reduction in mother-to-child transmission of human immunodeficiency virus (HIV) is regarded as one of the most effective public health initiatives in the United States. In the absence of treatment, the risk of vertical transmission of...
https://doi.org/10.1111/hiv.12720
HIV Medicine; Gilleece DY, Tariq DS et. al.
Mar 14th, 2019 - British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018.|2019|Gilleece DY,Tariq DS,Bamford DA,Bhagani DS,Byrne DL,|diagnosis,drug therapy,diagnosis,drug therapy,
News 7 results
https://reference.medscape.com/viewarticle/911214_3
Apr 2nd, 2019 - Neonatal Management Two weeks of zidovudine monotherapy should be used if the mother has been on cART for more than 10 weeks, has two recorded maternal HIV viral loads during pregnancy <50 HIV RNA copies/mL at least 4 weeks apart, and a maternal H...
https://reference.medscape.com/viewarticle/911214
Apr 2nd, 2019 - The guidelines on management of HIV in pregnancy and postpartum were released on March 14, 2019, by the British HIV Association (BHIVA).[1] Screening Pregnant women living with HIV should be offered peer support if it is available. Evaluation of a...
https://www.medscape.com/viewarticle/838377
Jan 19th, 2015 - Socially disadvantaged HIV-infected women who start highly active retroviral therapy (HAART) for the first time during pregnancy may be at higher risk for detectable virus at delivery than their better-off peers, according to a study published in...
https://www.staging.medscape.com/viewarticle/838377
Jan 19th, 2015 - Socially disadvantaged HIV-infected women who start highly active retroviral therapy (HAART) for the first time during pregnancy may be at higher risk for detectable virus at delivery than their better-off peers, according to a study published in...
https://www.mdedge.com/familymedicine/article/58977/hiv-pregnancy-update/page/0/1
Family Practice News;
May 30th, 2013 - Some state laws do not allow opt-out testing and still require affirmative consent, however, so it is important to know your state’s laws. Regardless of your state’s situation, however, failing to test because you deem a patient unlikely to be inf.